CA9 and neoplasm: Importantly, the administration of CAIX-specific inhibitor SLC-0111 to mice bearing PDAC xenografts reduced tumor growth compared with gemcitabine alone, while increasing their sensitivity to gemcitabine and significantly prolonging survival.